What question did this study set out to answer?

This research aims to understand the adherence levels to dabigatran etexilate among patients requiring anticoagulation therapy.

July 1, 2009Patient Preference and AdherenceOpen Access

Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate

Q: What is the clinical evidence from this study?

Study design: Review. Population: Atrial fibrillation and major orthopedic surgery. Intervention: Dabigatran etexilate vs. Vitamin K antagonists (VKA) and low-molecular-weight heparins.

View Full Paper

Ask AI

Bookmark

Key result

Dabigatran etexilate provides a convenient oral alternative for thromboprophylaxis without coagulation monitoring, though patient education remains essential to ensure adherence.

Why the study?

Does dabigatran etexilate improve adherence to thromboprophylaxis compared to traditional anticoagulants in patients with atrial fibrillation or post-orthopedic surgery?

Population

Patients requiring thromboprophylaxis for conditions such as atrial fibrillation or after major orthopedic…

Comparison

Dabigatran etexilate vs Vitamin K antagonists or low-molecular-weight…

Design

Review

Authors

NRNadia RosencherGeneral / Preventive / Lipids

Discussion

Member takes

Implication

May support dabigatran convenience for thromboprophylaxis; leaves open adherence gains versus traditional agents without targeted education.

Key Points

This research aims to understand the adherence levels to dabigatran etexilate among patients requiring anticoagulation therapy.
Evaluated patient adherence levels to dabigatran etexilate prescriptions.
Analyzed factors impacting adherence such as patient understanding, motivation, and socio-economic status.
Adherence to oral anticoagulant treatments like dabigatran is complex and influenced by various patient factors.
Education about the medication and addressing risk factors are crucial for improving adherence.

Structured PICO

Does dabigatran etexilate improve adherence to thromboprophylaxis compared to traditional anticoagulants in patients with atrial fibrillation or post-orthopedic surgery?

Population

Patients requiring thromboprophylaxis for conditions such as atrial fibrillation or after major orthopedic surgery

Intervention

Dabigatran etexilate

Comparator

Vitamin K antagonists (VKA) or low-molecular-weight heparins

Outcome

Adherence to treatment

While new oral anticoagulants offer convenience, ensuring adherence requires ongoing patient education and monitoring of nonadherence risk factors.

Limitations

Adherence to oral treatments is complex and depends on dosing frequency, patient motivation, understanding, and socio-economic status.

Cite This Study

Nadia Rosencher (2009) conducted a review in Atrial fibrillation and major orthopedic surgery. Dabigatran etexilate vs. Vitamin K antagonists (VKA) and low-molecular-weight heparins was evaluated. Dabigatran etexilate provides a convenient oral alternative for thromboprophylaxis without coagulation monitoring, though patient education remains essential to ensure adherence.

synapsesocial.com/papers/6a69de917c724b9ecf480b79 https://doi.org/10.2147/ppa.s3682

View Full Paper

Ask AI

Bookmark

Implication

May support dabigatran convenience for thromboprophylaxis; leaves open adherence gains versus traditional agents without targeted education.

Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Adherence to a new oral anticoagulant treatment prescription: dabigatran etexilate

Discussion

Member takes

Implication

Key Points

Structured PICO

Limitations

Cite This Study

Also Consider

Also Consider